Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073966 | SCV001239531 | likely pathogenic | Retinal dystrophy | 2018-08-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857414 | SCV002240955 | pathogenic | Cone-rod dystrophy 6; Leber congenital amaurosis 1 | 2023-09-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.His967Ilefs*11) in the GUCY2D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GUCY2D are known to be pathogenic (PMID: 10951519, 11328726). This variant is present in population databases (rs751295073, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with GUCY2D-related conditions. ClinVar contains an entry for this variant (Variation ID: 98579). For these reasons, this variant has been classified as Pathogenic. |
Retina International | RCV000084874 | SCV000117010 | not provided | not provided | no assertion provided | not provided | ||
Laboratory of Genetics in Ophthalmology, |
RCV001250883 | SCV001426375 | pathogenic | Leber congenital amaurosis 1 | no assertion criteria provided | research |